Insider Ledger
OKUR insider buying and SEC filings, explained
OnKure Therapeutics, Inc. · CIK 1637715
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Reneo Pharmaceuticals, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$6K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 21, 2026 | Sale | Jason A. Leverone (CFO) sold 302 shares at about $2.97 ($897). Holdings down 2% to 18,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 23, 2026 |
| Sep 21, 2026 | Sale | Nicholas A Saccomano (CEO and Director) sold 87 shares at about $2.97 ($258). Holdings down 1% to 11,160 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 23, 2026 |
| Jun 22, 2026 | Sale | Jason A. Leverone (CFO) sold 303 shares at about $4.40 ($1K). Holdings down 2% to 18,802 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 24, 2026 |
| Jun 22, 2026 | Sale | Nicholas A Saccomano (CEO and Director) sold 86 shares at about $4.40 ($378). Holdings down 1% to 11,247 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 24, 2026 |
| Mar 23, 2026 | Sale | Jason A. Leverone (CFO) sold 301 shares at about $4.16 ($1K). Holdings down 2% to 16,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 24, 2026 |
| Mar 23, 2026 | Sale | Nicholas A Saccomano (CEO and Director) sold 86 shares at about $4.16 ($358). Holdings down 1% to 7,333 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 24, 2026 |
| Dec 22, 2025 | Sale | Jason A. Leverone (CFO) sold 302 shares at about $2.97 ($897). Holdings down 2% to 16,301 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 23, 2025 |
| Dec 22, 2025 | Sale | Nicholas A Saccomano (CEO and Director) sold 87 shares at about $2.97 ($258). Holdings down 1% to 7,419 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 23, 2025 |
24 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow OKUR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.